Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 10/20 | 0.46 |
| ▸ | PDK2 | Q15119 | 3/20 | 0.46 |
| ▸ | TRPV4 | Q9HBA0 | 1/20 | 0.44 |
| ▸ | KIF11 | P52732 | 1/20 | 0.43 |
| ▸ | PGR | P06401 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | PTGDR2 | Q9Y5Y4 | 1/20 | 0.40 |
| ▸ | ACP1 | P24666 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21046587 | 1.00 | AR (0.46) | ARPDK2TRPV4KIF11PGR | |
| SCHEMBL2371259 | 0.92 | AR (0.47) | ARPDK2TRPV4KIF11PGR | |
| SCHEMBL7604551 | 0.85 | TRPV4 (0.56) | ARPDK2TRPV4KIF11GLA | |
| SCHEMBL28668535 | 0.82 | KIF11 (0.57) | ARPDK2TRPV4KIF11PGR | |
| SCHEMBL12855308 | 0.81 | PTGDR2 (0.50) | PDK2PTGDR2 | |
| SCHEMBL20740894 | 0.81 | PTGDR2 (0.50) | PDK2PTGDR2 | |
| SCHEMBL4450178 | 0.78 | KIF11 (0.59) | PDK2KIF11ALDH1A1PTGDR2 | |
| SCHEMBL17955138 | 0.78 | KIF11 (0.53) | ARPDK2TRPV4KIF11KDM4E | |
| SCHEMBL3422472 | 0.77 | PTGDR2 (0.53) | PDK2PTGDR2 | |
| SCHEMBL29143031 | 0.77 | GLA (0.43) | ARKIF11ALDH1A1GLAGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11444250-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2022-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11444250-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, ALDH1A2, CYBA | AR 4237/4885PDK2 842/4885TRPV4 632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.